Andere Sprachen ReShape Lifesciences Inc.

Aktien

A3D3E9

US76090R2004

RSLS

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:01 03.05.2024			% 5 Tage	% 1. Jan.
0,1693 ^USD	-3,42 %		-0,29 %	-32,20 %

01.04.	Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024
01.04.	ReShape Lifesciences Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

North American Morning Briefing : Big Banks Kick -2-	12.04.
ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update	01.04.
ReShape Lifesciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01.04.
Certain Restricted Stock Units of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	30.03.
Certain Warrants of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	30.03.
Certain Options of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	30.03.
Certain Common Stock of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	30.03.
ReShape Lifesciences Gets US Patent for Intragastric Balloon Weight-Loss System	28.03.
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System	28.03.
ReShape Lifesciences Receives Notice of Allowance for Additional U.S. Patent Related to Intragastric Balloon System	28.03.
ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX	04.03.
ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX	22.02.
Reshape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band 2.0 Flex	22.02.
ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX	24.01.
ReShape Lifesciences announces FDA PMA supplement approval for next-gen Lap-Band 2.0 Flex	21.12.
ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives	20.12.
Wall Street op nieuwe jaarrecords gesloten	13.12.
Top Midday Gainers	13.12.
Wall Street in afwachting van rentebesluit	13.12.
Licht hogere start voor Wall Street	13.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen ReShape Lifesciences Inc.

Aktien

A3D3E9

US76090R2004

RSLS

Andere Sprachen

Filter